| Emittent | Gattung | Typ | CUSIP/ISIN | Richtung | Bewertungsbasis | Handel | Bestand ($) | % NAV | Stück / Nennwert |
|---|---|---|---|---|---|---|---|---|---|
| 136.672.316 $ | 96,73 | 906.253 | |||||||
| Eli Lilly & Co. | Eli Lilly & Co. | EC | 532457108 | Long | Börsenkurs (Stufe 1) | 15.194.600 $ | 10,75 | 16.520 | |
| Johnson & Johnson | Johnson & Johnson | EC | 478160104 | Long | Börsenkurs (Stufe 1) | 12.963.142 $ | 9,17 | 53.032 | |
| AbbVie, Inc. | AbbVie, Inc. | EC | 00287Y109 | Long | Börsenkurs (Stufe 1) | 8.503.859 $ | 6,02 | 39.100 | |
| Novartis AG | Novartis AG | EC | CH0012005267 | Long | Modellwert (Stufe 2) | 7.395.976 $ | 5,23 | 48.184 | |
| Merck & Co., Inc. | Merck & Co., Inc. | EC | 58933Y105 | Long | Börsenkurs (Stufe 1) | 6.982.353 $ | 4,94 | 58.046 | |
| UnitedHealth Group, Inc. | UnitedHealth Group, Inc. | EC | 91324P102 | Long | Börsenkurs (Stufe 1) | 6.964.987 $ | 4,93 | 25.740 | |
| AstraZeneca plc | AstraZeneca plc | EC | GB0009895292 | Long | Modellwert (Stufe 2) | 6.947.927 $ | 4,92 | 35.532 | |
| Thermo Fisher Scientific, Inc. | Thermo Fisher Scientific, Inc. | EC | 883556102 | Long | Börsenkurs (Stufe 1) | 6.370.229 $ | 4,51 | 12.960 | |
| Intuitive Surgical, Inc. | Intuitive Surgical, Inc. | EC | 46120E602 | Long | Börsenkurs (Stufe 1) | 5.734.716 $ | 4,06 | 12.440 | |
| Sanofi SA | Sanofi SA | EC | FR0000120578 | Long | Modellwert (Stufe 2) | 5.055.624 $ | 3,58 | 52.352 | |
| Boston Scientific Corp. | Boston Scientific Corp. | EC | 101137107 | Long | Börsenkurs (Stufe 1) | 3.919.993 $ | 2,77 | 62.470 | |
| Gilead Sciences, Inc. | Gilead Sciences, Inc. | EC | 375558103 | Long | Börsenkurs (Stufe 1) | 3.846.612 $ | 2,72 | 27.600 | |
| Roche Holding AG | Roche Holding AG | EC | CH1499059983 | Long | Modellwert (Stufe 2) | 3.723.518 $ | 2,64 | 9.330 | |
| McKesson Corp. | McKesson Corp. | EC | 58155Q103 | Long | Börsenkurs (Stufe 1) | 3.513.362 $ | 2,49 | 4.060 | |
| Cardinal Health, Inc. | Cardinal Health, Inc. | EC | 14149Y108 | Long | Börsenkurs (Stufe 1) | 3.190.781 $ | 2,26 | 15.100 | |
| Vertex Pharmaceuticals, Inc. | Vertex Pharmaceuticals, Inc. | EC | 92532F100 | Long | Börsenkurs (Stufe 1) | 3.161.503 $ | 2,24 | 7.080 | |
| Bristol-Myers Squibb Co. | Bristol-Myers Squibb Co. | EC | 110122108 | Long | Börsenkurs (Stufe 1) | 3.087.085 $ | 2,18 | 50.900 | |
| CVS Health Corp. | CVS Health Corp. | EC | 126650100 | Long | Börsenkurs (Stufe 1) | 3.045.168 $ | 2,16 | 42.400 | |
| Edwards Lifesciences Corp. | Edwards Lifesciences Corp. | EC | 28176E108 | Long | Börsenkurs (Stufe 1) | 2.898.896 $ | 2,05 | 36.200 | |
| Ascendis Pharma A/S | Ascendis Pharma A/S | EC | 04351P101 | Long | Börsenkurs (Stufe 1) | 2.118.955 $ | 1,50 | 9.264 | |
| HCA Healthcare, Inc. | HCA Healthcare, Inc. | EC | 40412C101 | Long | Börsenkurs (Stufe 1) | 2.082.256 $ | 1,47 | 4.400 | |
| Amgen, Inc. | Amgen, Inc. | EC | 031162100 | Long | Börsenkurs (Stufe 1) | 2.054.804 $ | 1,45 | 5.840 | |
| Medtronic plc | Medtronic plc | EC | IE00BTN1Y115 | Long | Börsenkurs (Stufe 1) | 2.044.940 $ | 1,45 | 23.600 | |
| Hoya Corp. | Hoya Corp. | EC | JP3837800006 | Long | Modellwert (Stufe 2) | 1.837.621 $ | 1,30 | 10.600 | |
| UCB SA | UCB SA | EC | BE0003739530 | Long | Modellwert (Stufe 2) | 1.567.044 $ | 1,11 | 5.201 | |
| Regeneron Pharmaceuticals, Inc. | Regeneron Pharmaceuticals, Inc. | EC | 75886F107 | Long | Börsenkurs (Stufe 1) | 1.456.426 $ | 1,03 | 1.885 | |
| Argenx SE | Argenx SE | EC | NL0010832176 | Long | Modellwert (Stufe 2) | 1.434.060 $ | 1,01 | 1.976 | |
| Insmed, Inc. | Insmed, Inc. | EC | 457669307 | Long | Börsenkurs (Stufe 1) | 1.406.272 $ | 1,00 | 8.600 | |
| GSK plc | GSK plc | EC | GB00BN7SWP63 | Long | Modellwert (Stufe 2) | 1.351.767 $ | 0,96 | 49.074 | |
| Chugai Pharmaceutical Co. Ltd. | Chugai Pharmaceutical Co. Ltd. | EC | JP3519400000 | Long | Modellwert (Stufe 2) | 1.307.019 $ | 0,92 | 23.700 | |
| Rhythm Pharmaceuticals, Inc. | Rhythm Pharmaceuticals, Inc. | EC | 76243J105 | Long | Börsenkurs (Stufe 1) | 1.017.549 $ | 0,72 | 11.700 | |
| United Therapeutics Corp. | United Therapeutics Corp. | EC | 91307C102 | Long | Börsenkurs (Stufe 1) | 901.330 $ | 0,64 | 1.520 | |
| Novo Nordisk A/S | Novo Nordisk A/S, Class B | EC | DK0062498333 | Long | Modellwert (Stufe 2) | 777.523 $ | 0,55 | 21.247 | |
| Xenon Pharmaceuticals, Inc. | Xenon Pharmaceuticals, Inc. | EC | 98420N105 | Long | Börsenkurs (Stufe 1) | 755.950 $ | 0,53 | 13.000 | |
| IQVIA Holdings, Inc. | IQVIA Holdings, Inc. | EC | 46266C105 | Long | Börsenkurs (Stufe 1) | 716.268 $ | 0,51 | 4.200 | |
| Revolution Medicines, Inc. | Revolution Medicines, Inc. | EC | 76155X100 | Long | Börsenkurs (Stufe 1) | 612.675 $ | 0,43 | 6.300 | |
| Terns Pharmaceuticals, Inc. | Terns Pharmaceuticals, Inc. | EC | 880881107 | Long | Börsenkurs (Stufe 1) | 390.128 $ | 0,28 | 7.400 | |
| Precigen, Inc. | Precigen, Inc. | EC | 74017N105 | Long | Börsenkurs (Stufe 1) | 339.399 $ | 0,24 | 87.700 | |
| 136.672.316 $ | 96,73 | 906.253 |